Entity Common Stock, Shares Outstanding of Arbutus Biopharma Corp from 31 Dec 2011 to 11 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Arbutus Biopharma Corp quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Dec 2011 to 11 Nov 2025.
  • Arbutus Biopharma Corp Entity Common Stock, Shares Outstanding for the quarter ending 11 Nov 2025 was 192,324,017, a 1.5% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Arbutus Biopharma Corp Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 192,324,017 +2,832,332 +1.5% 11 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 191,698,695 +2,916,666 +1.5% 04 Aug 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 191,480,188 +2,762,779 +1.5% 25 Mar 2025 10-K 27 Mar 2025 2024 FY
Q3 2024 189,491,685 +21,796,438 +13% 05 Nov 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 188,782,029 +21,225,368 +13% 07 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 188,717,409 +26,146,420 +16% 30 Apr 2024 10-Q 02 May 2024 2024 Q1
Q3 2023 167,695,247 +11,228,162 +7.2% 03 Nov 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 167,556,661 +17,606,055 +12% 01 Aug 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 162,570,989 +13,929,253 +9.4% 28 Feb 2023 10-K 02 Mar 2023 2022 FY
Q3 2022 156,467,085 +21,197,838 +16% 08 Nov 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 149,950,606 +50,789,372 +51% 02 Aug 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 148,641,736 +53,057,821 +56% 03 Mar 2022 10-K 03 Mar 2022 2021 FY
Q3 2021 135,269,247 +50,359,989 +59% 02 Nov 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 99,161,234 +18,251,975 +23% 03 Aug 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 95,583,915 +26,642,509 +39% 03 Mar 2021 10-K 04 Mar 2021 2020 FY
Q3 2020 84,909,258 +28,059,086 +49% 05 Nov 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 80,909,259 +24,059,087 +42% 05 Aug 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 68,941,406 +12,820,538 +23% 02 Mar 2020 10-K 05 Mar 2020 2019 FY
Q3 2019 56,850,172 +1,372,937 +2.5% 31 Oct 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 56,850,172 +1,445,874 +2.6% 31 Jul 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 56,120,868 +1,050,831 +1.9% 05 Mar 2019 10-K 07 Mar 2019 2018 FY
Q3 2018 55,477,235 +425,240 +0.77% 31 Oct 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 55,404,298 +377,303 +0.69% 31 Jul 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 55,070,037 +46,830 +0.08% 06 Mar 2018 10-K 16 Mar 2018 2017 FY
Q3 2017 55,051,995 +210,501 +0.38% 31 Oct 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 55,026,995 +230,254 +0.42% 31 Jul 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 55,023,207 +397,504 +0.73% 14 Mar 2017 10-K 22 Mar 2017 2016 FY
Q3 2016 54,841,494 +271,703 +0.5% 31 Oct 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 54,796,741 +468,327 +0.86% 31 Jul 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 54,625,703 +8,058,207 +17% 30 Apr 2016 10-Q 04 May 2016 2016 Q1
Q3 2015 54,569,791 +32,463,814 +147% 31 Oct 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 54,328,414 +32,222,437 +146% 31 Jul 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 46,567,496 +24,621,658 +112% 09 Mar 2015 10-K 13 Mar 2015 2014 FY
Q3 2014 22,105,977 06 Nov 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 22,105,977 12 Aug 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 21,945,838 21 Mar 2014 10-K 28 Mar 2014 2013 FY
Q4 2012 14,305,356 +2,156,720 +18% 31 Dec 2012 20-F 27 Mar 2013 2012 FY
Q4 2011 12,148,636 31 Dec 2011 20-F 27 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.